DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
McDermott DF, Regan MM, Clark JI et al.
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.
J Clin Oncol 2005;
23: 133-141
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.